You searched for T cells - Page 2 of 41

News and Trends 16 Oct 2017

Interview: On the Future of iPS Cells and why Partnering is so Important in this Field

…what novel research is taking place to address these? Researchers hope that iPS Cells will help in therapies surrounding neurodegenerative diseases The research community continues to invest heavily into the…

October 16, 2017 - 9 minutesmins - By External Contributor

Best in Biotech 30 May 2024

Stem cell therapy’s avant-garde: Eight companies leading the way

…treat Parkinson’s disease. This therapy uses dopamine-producing neurons derived from human pluripotent stem cells, which are surgically implanted into the patient’s brain. These cells have the potential to re-establish neural…

May 30, 2024 - 11 minutesmins - By Jules Adam

News and Trends 22 Nov 2017

Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells

…cells with their own, which are geared up to better tracking down and killing cancer cells. The research reported in Blood explained how the group removed receptors that interact with…

November 22, 2017 - 3 minutesmins - By Alex Dale

News and Trends 13 Jun 2018

French Biotech Develops a New Generation of Safer CAR-T Cells

…therapies. The technology, called CubiCAR, makes it easier for CAR-T cells to be detected and purified in the production process. Additionally, it allows CAR-T cells to be killed with the…

June 13, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…therapy: distinguishing cancer cells from normal cells to minimize damage to healthy tissues. The Tmod system involves a two-step process. First, it uses a ‘blocking’ receptor to identify a target…

June 13, 2024 - 9 minutesmins - By Jules Adam

Best in Biotech 2 Jul 2024

Swiss biotech going strong in 2024: 18 companies to put on your radar

…focused on developing advanced therapies for the treatment of solid tumors. They specialize in creating soluble T-cell receptor (TCR) therapies that are designed to target cancer cells with high precision…

July 2, 2024 - 20 minutesmins - By Jules Adam

News and Trends 29 Oct 2015

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

…Covering Allogeneic Chimeric Antigen Receptor T Cells (“CAR-T”) Modified to Reduce Immunogenicity”. The patent is specific to TCR-deficient allogeneic (not from the donor) CAR-T cells and covers applications in the…

October 29, 2015 - 3 minutesmins - By Philip Hemme

In Depth 24 Jan 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

…and T cells differ in the sense that B cells produce antibodies to attack invading bacteria, viruses, and toxins, while T cells destroy the body’s own cells that have already…

January 24, 2024 - 7 minutesmins - By Willow Shah-Neville

In Depth 15 Sep 2021

Blood Cells: The Future of Drug Delivery

…are loaded onto the red blood cells, another solution is used to reseal the cell’s membrane before infusing the cells into the patient. Another company that is working on red…

September 15, 2021 - 7 minutesmins - By Sachin Rawat

Interview 28 Oct 2020

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

…strains. That’s the ultimate goal of this program.” Just recently, the FDA approved a phase I/II clinical trial that will test the effects of Kiadis’ off-the-shelf NK cell therapy platform…

October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

In Depth 11 Jul 2017

Regenerating the Body With Stem Cells – Hype or Hope?

…recently acknowledged that it took about $1.5M and 6 months to treat each patient. It’s a great idea but it’s still got some way to go before it reaches the…

July 11, 2017 - 9 minutesmins - By Melanie De Almeida

den bosch netherlands lava therapeutics cancer immunotherapy

Startup Scout 23 Nov 2018

This Biotech Arms Tumor-Busting Cells to Treat Cancer

…antibodies that recruit innate immune cells near tumors and activate them to kill cancer cells. T cells are immune cells that have a strong potential for use in cancer immunotherapies,…

November 23, 2018 - 3 minutesmins - By Jonathan Smith

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

Interview: On the Future of iPS Cells and why Partnering is so Important in this Field

Stem cell therapy’s avant-garde: Eight companies leading the way

Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells

French Biotech Develops a New Generation of Safer CAR-T Cells

Eight companies tackling cancer with allogeneic cell therapy in 2024

Swiss biotech going strong in 2024: 18 companies to put on your radar

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Blood Cells: The Future of Drug Delivery

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

Regenerating the Body With Stem Cells – Hype or Hope?

This Biotech Arms Tumor-Busting Cells to Treat Cancer

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!